Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析

◆英語タイトル:Arrowhead Pharmaceuticals Inc (ARWR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15080
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, thrombosis and angioedema, cardiovascular disease and clear cell and renal cell carcinoma, among others. It offers design of internal preclinical and clinical development programs to enable novel new therapies. Arrowhead develops pipeline products such as ARO-AAT, ARO-HBV, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, AMG 890 and ARO-AMG1. The company has operations in California and Wisconsin. Arrowhead is headquartered in Pasadena, California, the US.

Arrowhead Pharmaceuticals Inc Key Recent Developments

Feb 07,2019: Arrowhead Pharmaceuticals reports fiscal 2019 first quarter results
Dec 11,2018: Arrowhead Pharmaceuticals reports fiscal 2018 year end results
Oct 15,2018: Arrowhead Pharmaceuticals files for regulatory clearance to begin phase 1 study of ARO-ANG3
Oct 05,2018: Janssen signs $3.7bn worth licence agreements with Arrowhead
Sep 24,2018: Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics

This comprehensive SWOT profile of Arrowhead Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Arrowhead Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Arrowhead Pharmaceuticals Inc – Key Information
Arrowhead Pharmaceuticals Inc – Overview
Arrowhead Pharmaceuticals Inc – Key Employees
Arrowhead Pharmaceuticals Inc – Key Employee Biographies
Arrowhead Pharmaceuticals Inc – Key Operational Heads
Arrowhead Pharmaceuticals Inc – Major Products and Services
Arrowhead Pharmaceuticals Inc – History
Arrowhead Pharmaceuticals Inc – Company Statement
Arrowhead Pharmaceuticals Inc – Locations And Subsidiaries
Arrowhead Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Arrowhead Pharmaceuticals Inc – Business Description
Arrowhead Pharmaceuticals Inc – Corporate Strategy
Arrowhead Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Arrowhead Pharmaceuticals Inc – Strengths
Arrowhead Pharmaceuticals Inc – Weaknesses
Arrowhead Pharmaceuticals Inc – Opportunities
Arrowhead Pharmaceuticals Inc – Threats
Arrowhead Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Arrowhead Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Arrowhead Pharmaceuticals Inc, Key Information
Arrowhead Pharmaceuticals Inc, Key Ratios
Arrowhead Pharmaceuticals Inc, Share Data
Arrowhead Pharmaceuticals Inc, Major Products and Services
Arrowhead Pharmaceuticals Inc, History
Arrowhead Pharmaceuticals Inc, Key Employees
Arrowhead Pharmaceuticals Inc, Key Employee Biographies
Arrowhead Pharmaceuticals Inc, Key Operational Heads
Arrowhead Pharmaceuticals Inc, Other Locations
Arrowhead Pharmaceuticals Inc, Subsidiaries
Arrowhead Pharmaceuticals Inc, Key Manufacturing facilities
Arrowhead Pharmaceuticals Inc, Key Competitors
Arrowhead Pharmaceuticals Inc, SWOT Analysis
Arrowhead Pharmaceuticals Inc, Ratios based on current share price
Arrowhead Pharmaceuticals Inc, Annual Ratios
Arrowhead Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Arrowhead Pharmaceuticals Inc, Performance Chart
Arrowhead Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ardent Health Services:企業の戦略・SWOT・財務分析
    Ardent Health Services - Strategy, SWOT and Corporate Finance Report Summary Ardent Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kracie Holdings, Ltd.:企業の戦略・SWOT・財務情報
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • DEME NV:電力:M&Aディール及び事業提携情報
    Summary DEME N.V. (DEME), a subsidiary of Compagnie d'Entreprises CFE SA is a dredging and hydraulic engineering services company. The company offers services, which include engineering solutions, installation of offshore wind farms, services to oil and gas companies, environmental activities such a …
  • Samsung C&T Corporation:企業の戦略・SWOT・財務情報
    Samsung C&T Corporation - Strategy, SWOT and Corporate Finance Report Summary Samsung C&T Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ohr Pharmaceutical Inc (OHRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • Joint Stock Company Russian Agricultural Bank:企業の戦略・SWOT・財務分析
    Joint Stock Company Russian Agricultural Bank - Strategy, SWOT and Corporate Finance Report Summary Joint Stock Company Russian Agricultural Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Jungbunzlauer Suisse AG:企業の戦略・SWOT・財務情報
    Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report Summary Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nippon Telegraph and Telephone Corp (9432):企業の財務・戦略的SWOT分析
    Nippon Telegraph and Telephone Corp (9432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Botswana Power Corp:企業の戦略的SWOT分析
    Botswana Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • ResApp Health Ltd (RAP):医療機器:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Mercury NZ:戦略・SWOT・企業財務分析
    Mercury NZ - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • American Municipal Power Inc:企業の戦略的SWOT分析
    American Municipal Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Mgm China Holdings Ltd
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • CytoSorbents Corp (CTSO)-製薬・医療分野:企業M&A・提携分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme system …
  • L-3 Unmanned Systems, Inc.:企業の戦略・SWOT・財務分析
    L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆